Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q2 2025 (June 30)5holders
0new positions
0sold out
$6.35avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($134K), Rhumbline Advisers ($76K) and PNC Financial Services Group, Inc. ($20K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 577 shares bought and 756 shares sold, net −179 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.01% | No change | 21,098 | $134K |
| Rhumbline Advisers | 0.00% | Reduce -5.9% | 11,984 | $76K |
| PNC Financial Services Group, Inc. | 0.00% | Add +22.3% | 3,170 | $20K |
| GAMMA Investing LLC | 0.00% | No change | 256 | $2K |
| Brooklyn Investment Group | 0.00% | No change | 40 | $262 |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.